A massive long-term study tracking more than 650,000 Americans with irritable bowel syndrome is raising new concerns about the safety of some commonly used treatments. A major long-term study led by researchers at Cedars-Sinai Health Sciences University is shedding new light on the safety of medications commonly used to treat irritable bowel syndrome (IBS). The [...]from SciTechDaily https://ift.tt/z9RkT7m
